Control of hormonal rhinitis symptoms in patients with hypothyrosis: pathogenetic and clinical aspects

Kryukov A.I.; Chernykh N.M.; Nosulya E.V.; Kunelskaya N.L.; Kim I.A.; Karnoukhova O.G.

doi:https://doi.org/10.17116/otorino20228804154

Kryukov A.I.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-0149-0676

Chernykh N.M.

Irkutsk State Medical University of the Ministry of Health of the Russian Federation

ORCID: 0000-0003-1303-5010

Nosulya E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-3897-8384

Kunelskaya N.L.

L. I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-1001-2609

Kim I.A.

N.I. Pirogov Russian National Research Medical University;
National Medical Research Center of Otorhinolaryngology of Federal Medical-Biological Agency

ORCID: 0000-0003-1078-6388

Karnoukhova O.G.

Irkutsk State Medical University of the Ministry of Health of the Russian Federation

ORCID: 0000-0003-1026-8417

Control of hormonal rhinitis symptoms in patients with hypothyrosis: pathogenetic and clinical aspects

Authors:

Kryukov A.I., Chernykh N.M., Nosulya E.V., Kunelskaya N.L., Kim I.A., Karnoukhova O.G.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2023;88(4): 54‑60

DOI: 10.17116/otorino20228804154

Read: 2153 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kryukov AI, Chernykh NM, Nosulya EV, Kunelskaya NL, Kim IA, Karnoukhova OG. Control of hormonal rhinitis symptoms in patients with hypothyrosis: pathogenetic and clinical aspects. Russian Bulletin of Otorhinolaryngology. 2023;88(4):54‑60. (In Russ.)
https://doi.org/10.17116/otorino20228804154

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)

Использование инфографики авторами научных работ

Close metadata

BACKGROUND

One of the poorly studied sections of the pathology of ENT organs is chronic rhinitis in patients with hypothyroidism, the pathogenesis of which has not been fully understood, the diagnosis causes significant difficulties, and there are no recommendations for treatment. Despite receiving replacement therapy with levothyroxine, the symptoms of rhinitis persist.

OBJECTIVE

To study the effectiveness of the use of intranasal glucocorticosteroids in patients with chronic rhinitis and hypothyroidism.

MATERIAL AND METHODS

Patients with chronic rhinitis and hypothyroidism used mometasone nasal spray 100 mcg 1 time per day for a course of treatment of 2 months (n=60). To assess the symptoms of rhinitis, a visual analog scale (0—10 points), endoscopic examination of ENT organs, anterior active rhinomanometry were used. Evaluation of mucociliary transport was used a saccharin test. The concentration of transforming growth factor (TGF-β1) in nasal secretion and blood serum was studied by ELISA (Enzyme-Linked Immunosorbent Assay), the number of metabolites of NO — nitrites+nitrates (NO_x) was recorded by colorimetric method.

RESULTS

The use of mometasone nasal spray in patients with hypothyroidism helped to reduce complaints on a visual-analog scale (difficulty in nasal breathing, rhinorrhea) and improve nasal breathing according to anterior active rhinomanometry. The concentrations of TGF-β1 and NO_x in nasal secretions before mometasone treatment were higher than after treatment, which probably indicates the contribution of these substances to the formation of edematous hypertrophic changes from the nose in patients with hypothyroidism.

Keywords:

hypothyroidism

chronic rhinitis

intranasal glucocorticosteroids

transforming growth factor β1

nitric oxide

Authors:

Kryukov A.I.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-0149-0676

Chernykh N.M.

Irkutsk State Medical University of the Ministry of Health of the Russian Federation

ORCID: 0000-0003-1303-5010

Nosulya E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-3897-8384

Kunelskaya N.L.

L. I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-1001-2609

Kim I.A.

N.I. Pirogov Russian National Research Medical University;
National Medical Research Center of Otorhinolaryngology of Federal Medical-Biological Agency

ORCID: 0000-0003-1078-6388

Karnoukhova O.G.

Irkutsk State Medical University of the Ministry of Health of the Russian Federation

ORCID: 0000-0003-1026-8417

Received:

18.01.2022

Accepted:

25.05.2023

Close metadata

References:

Kaliner MA, Baraniuk JN, Benninger M, Lieberman P, Meltzer EO, Naclerio RM, Settipane RA, Farrar JR. Consensus definition of nonallergic rhinopathy, previously referred to as vasomotor rhinitis, nonallergic rhinitis, and/or idiopathic rhinitis. World Allergy Organization Journal. 2009;2(6):119-120. https://doi.org/10.1097/wox.0b013e3181a8e15a
Scarupa MD, Kaliner MA. Nonallergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations. World Allergy Organization Journal. 2009;2(3):20-25. https://doi.org/10.1097/wox.0b013e3181990aac
Chernykh NM, Gaydarov GM, Nosulya EV, Kim IA. Epidemiology of hormonal rhinitis in iodine-deficient region of eastern Siberia. Rossijskaya rinologiya. 2020;28(2):81-87. (In Russ.). https://doi.org/10.17116/rosrino20202802181E
Kryukov AI, Studenyi ME, Artemiev ME, Chumakov PL, Rynkov DA, Gorin DS. Treatment of patients with rhinosinusitis: possibilities of conservative and operative treatment. Meditsinskij sovet. 2012;11:92-96. (In Russ.).
Tsarev SV. Allergic rhinitis: a modern assessment of medical and social aspects and methods of treatment of intranasal corticosteroids in the treatment of rhinitis. Meditsinskij sovet. 2018;17:187-191. (In Russ.).
Lyapin VA, Kazakovtsev VP. Case rate chronic diseases of the top respiratory tracts of adult population of the industrial centre according to retrospectives of the analysis. Rossijskaya otorinolaringologiya. 2013;2:69-71. (In Russ.).
Kryukov AI, Chernykh NM, Nosulya EV, Kunelskaya NL, Kim IA, Biryukova EV, Yushkina MA, Aleksanyan TA. Peculiarities of the ENT-organ condition in hypothyroidism. Vestnik otorinolaringologii. 2019;84(6):83-89. (In Russ.). https://doi.org/10.17116/otorino20198406183
Balabolkin MI, Klebanova EM, Kreminskaya VM. Fundamental’naya i klinicheskaya tiroidologiya. M.: Meditsina; 2007. (In Russ.).
Weisskopf A. Connective tissue: a synthesis of modern thought and its impact on the understanding of nasal disease. Laryngoscope. 1960;70:1029-1059. https://doi.org/10.1288/00005537-196008000-00001
Walsh TE. Vasomotor rhinitis. Laryngoscope. 1950;60(4):360-367. https://doi.org/10.1288/00005537-195004000-00006
Zagoryanskaya ME. The role of thyroid dysfunction in the development of vasomotor rhinitis. Zhurnal ushnykh, nosovykh i gorlovykh boleznej. 1970;5:63-67. (In Russ.).
Chumakov VI, Ageeva SA. Hypothyroidism and pathology of ENT organs (review). Vestnik otorinolaringologii. 1982;2:77-80. (In Russ.).
Kulekci Ozturk S, Sakci E, Kavvasoglu C. Rhinitis in patients with acquired hypothyroidism. European Archives of Oto-Rhino-Laryngology. 2021;278(1):87-92. https://doi.org/10.1007/s00405-020-06254-7
Golikov PP. Oksid azota v klinike neotlozhnykh zabolevanij. M.: Medpraktika-M; 2004. (In Russ.).
Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. British Journal of Pharmacology. 2006;147:193-201. https://doi.org/10.1038/sj.bjp.0706458
Guilherme de Toledo Leme Constantino1, Joño Ferreira de Mello Jr.2. Remodeling of the lower and upper airways. Brazilian Journal of Otorhinolaryngology. 2009;75(1):151-156. https://doi.org/10.1016/s1808-8694(15)30847-8
Sejima T, Holtappels G, Kikuchi H, Imayoshi S, Ichimura K, Bachert C. Cytokine profiles in Japanese patients with chronic rhinosinusitis. Allergology International. 2012;61(1):115-122. https://doi.org/10.2332/allergolint.10-OA-0290
Kitsera AE, Tomashevsky YaI, Soltan MA. Some changes in the upper respiratory tract in patients with autoimmune thyroiditis. ZhVNGKh. 1988;4:11-13. (In Russ.).
Simmons MW. Intranasal injection of corticosteroids. California Medicine. 1960;92(2):155-158.
Johns KJ, Chandra SR. Visual Loss Following Intranasal Corticosteroid Injection. JAMA. 1989;261(16):2413. https://doi.org/10.1001/jama.1989.03420160151041
Rettinger G, Christ P. Visual loss following intranasal injection. Rhinology. Supplement. 1989;9:66-72.
Barnes PJ. Nitric oxide and asthma. Research in Immunology. 1995;146(9):698-702. https://doi.org/10.1016/0923-2494(96)84921-2
Kim IA, Nosulya EV. Improvement of pathogenetic correction of postoperative changes of the nasal mucosa in modern rhinosurgery. Rossiiskaya otorinolaringologiya. 2009;1(38):184-187. (In Russ.).
Silvestri M, Sabatini F, Scarso L, Cordone A, Dasic G, Rossi GA. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. International Archives of Allergy and Immunology. 2002;128(1):51-58. https://doi.org/10.1159/000058003
Uchida J, Kanai K, Asano K, Watanabe S, Hisamitsu T, Suzaki H. Influence of fluticasone propionate on the production of vascular endothelial growth factor and basic fibroblast growth factor from nasal fibroblasts in vitro. In Vivo. 2004;18(6):767-770.
Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. The Journal of Biological Chemistry. 1994;269(7):4705-4708. https://doi.org/10.1016/s0021-9258(17)37600-7
Tavaf-Motamen H, Miner TJ, Starnes BW, Shea-Donohue T. Nitric oxide mediates acute lung injury by modulation of inflammation. Journal of Surgical Research. 1998;78(2):137-142. https://doi.org/10.1006/jsre.1998.5395
Nenasheva NM. Flixonase: new possibilities in the treatment of allergic rhinitis. Prakticheskij vrach. 1996;2:5-6. (In Russ.).
Brannan MD, Seiberling V, Cutler DL, Cuss F, Afrime M. Lack of systemic activity with intranasal mometasone furoate. Annals of Allergy, Asthma and Immunology. 1997;97:198. https://doi.org/10.1016/s0091-6749(96)80280-6